for up to 6 months after date of receipt. Avoid repeated
freeze/thaw cycles.
RELATED REFERENCES: Science (1991) 254:578-579.
FEBS Lett. (1991) 295:149-154.
Science (1991) 254:576-578.
PNAS (
sequence and chromosomal localization
(chromosome 17) of the GFAP gene. Acta
Neuropathol. 83(6), 569-578 (1992).
2. Zhu, H., and Dahlström, A., Glial fibrillary acidic
protein-expressing cells in
1992) 575:309-314; J. Neurochem. (1991) 57:1363-1369; BBRC (1992)
184:661-667; Brain Res. (1992) 578:244-250, Life. Sci. (1992) 51:1509-1516.
Important Note: During shipment, small volumes of product
c-MER (578-872) Active (M0948) - Datasheet
c-MER (578-872) Active
human, recombinant
GST-tagged, expressed in Sf9 cells
Catalog Number M0948
Lot Number 019K0640
Storage Temperature –70 °C
Analyte QC Level Expected Range Units Analyte QC Level Expected Range Units FAS Control 1 96 – 200 pg/mL IL-6 Control 1 433 – 899 pg/mL
Control 2 772 – 1603 pg/mL Control 2 3489
. Sabala, I. et al., BMC Microbiol., 12, 97 (2012).
2. Firczuk, M. et al., J. Mol. Biol., 354(3), 578-590
(2005).
3. Odintsov, S.G. et al., J. Mol. Biol., 335(3), 775-785
(2004).
4. Ramadurai
Methods in Mol. Biol.,
2012, 135-149 (2019).
2. Dennler, P. et al., Bioconjugate Chem., 25(3),
569-578 (2014).
Notice
We provide information and advice to our customers
on application technologies
Pharmacology. XXXIX. Compendium of voltage-
gated ion channels: sodium channels, Pharmacol
Rev., 55, 575-578 (2003).
3. Abriel, H. and Kass, R.S., Regulation of the
voltage-gated cardiac sodium channel Nav1.5
Pharmacology. XXXIX. Compendium of voltage-
gated ion channels: sodium channels, Pharmacol
Rev., 55, 575-578 (2003).
3. Abriel, H. and Kass, R.S., Regulation of the
voltage-gated cardiac sodium channel Nav1.5
glycerol.
Molecular mass: ∼131kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 578–782 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product is for R&D use only, not
glycerol.
Molecular mass: ∼131kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 578–782 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product is for R&D use only, not
glycerol.
Molecular mass: ∼131kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 578–782 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product is for R&D use only, not
in rabbit using a highly purified peptide RGPTITDKDR-
TKGPAE, corresponding to amino acid residues 578-
593 of rat KCNQ2 with an additional N-terminal
cysteine as the immunogen. The epitope is highly
Content Version: October 2020
For amplification of specific DNA fragments by PCR.
Cat. No. 11 578 553 001 1 kit
5 U/μl
100 reactions in a final volume of 50 μl
Store the kit
P-glycoprotein
inhibition by cyclosporin or verapamil. Tiberghien and Loor (1996) Anti-Cancer Drugs 7:568-578.
Introduction
Top Bottom
K562 cells were incubated in 0.4µm PCF black polystyrene 96-well
cyclosporin A or
verapamil. Tiberghien and Loor (1996) Anti Cancer Drugs 7:568-578.
A
B
0
50
100
150
200
250
0.0 0.1 1.0 10.0
[Cyclosporin] µg/ml
C
al
ce
in
Fuchsin/NABP
New Fuchsin/naphthol-AS-BI phosphate 5.0 mM NABP, 0.05% New
Fuchsin (w/v) in 200 mM Tris-HCl, pH 9.2, 6 mM sodium nitrite. Dis-
solve NABP first in dimethylsulfoxide and New Fuchsin in 2 M HCl
Fuchsin/NABP
New Fuchsin/naphthol-AS-BI phosphate 5.0 mM NABP, 0.05% New
Fuchsin (w/v) in 200 mM Tris-HCl, pH 9.2, 6 mM sodium nitrite. Dis-
solve NABP first in dimethylsulfoxide and New Fuchsin in 2 M HCl
,
2001 (4-6 fold faster) and Chen et al., 2001 (10-fold faster). The absolute values
are also similar to previous reports. For example Altomare et al., 2003 reported a
value of around 200 ms at -105